Loading…

Dynamics of reproductive genetic technologies: Perspectives of professional stakeholders

Reproductive and genetic medicine are evolving rapidly, and new technologies are already impacting current practices. This includes technologies that can identify a couples’ risk of having a child with a genetic disorder. Responsible implementation of new technologies requires evaluation of safety a...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2022-01, Vol.17 (6)
Main Authors: Ivy van Dijke, Carla G. van El, Phillis Lakeman, Mariëtte Goddijn, Tessel Rigter, Martina C. Cornel, Lidewij Henneman
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 6
container_start_page
container_title PloS one
container_volume 17
creator Ivy van Dijke
Carla G. van El
Phillis Lakeman
Mariëtte Goddijn
Tessel Rigter
Martina C. Cornel
Lidewij Henneman
description Reproductive and genetic medicine are evolving rapidly, and new technologies are already impacting current practices. This includes technologies that can identify a couples’ risk of having a child with a genetic disorder. Responsible implementation of new technologies requires evaluation of safety and ethics. Valuable insights for shaping governance processes are provided by various stakeholders involved, including healthcare professionals. Their willingness to adopt these technologies and guide the necessary systemic changes is required for the successful implementation of these technologies. In this study, twenty-one semi-structured interviews were conducted with professionals from different disciplines in the field of reproductive and genetic healthcare in the Netherlands. Three emerging technologies were discussed: expanded carrier screening (ECS), non-invasive prenatal diagnosis (NIPD) and germline genome editing (GGE). By probing stakeholders’ views, we explored how culture, structure and practice in healthcare is being shaped by innovations and changing dynamics in genetic and reproductive medicine. The general consensus was that the implementation of reproductive genetic technologies nationwide is a slow process in Dutch healthcare. A “typical Dutch approach” emerged that is characterized by restrictive legislation, broad support for people living with disabilities, values of an egalitarian society and limited commercialisation. Different scenarios for embedding ECS in future practice were envisioned, while implementation of NIPD in clinical practice was considered obvious. Views on GGE varied among stakeholders. Previous implementation examples in the Netherlands suggest introduction of new technology involves an organized collective learning process, with pilot studies and stepwise implementation. In addition, introducing and scaling up new technologies is complex due to perceived barriers from the legislative framework and the complex relationship between the government and stakeholders in this area. This paper describes how the international trends and advances of technologies are expected to manifest itself in a national setting.
format article
fullrecord <record><control><sourceid>doaj</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_e572ad266257477089377d1dde79084c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_e572ad266257477089377d1dde79084c</doaj_id><sourcerecordid>oai_doaj_org_article_e572ad266257477089377d1dde79084c</sourcerecordid><originalsourceid>FETCH-doaj_primary_oai_doaj_org_article_e572ad266257477089377d1dde79084c3</originalsourceid><addsrcrecordid>eNqtjUFqwzAQRUUg0DTpHXSBgCLFkp1t2tLuuugiOzFIY0eJ4jEat5Db15gcoasPn_f-X4jVrjF6a7UyT-KZ-aJUZWprV-L0eu_hlgJLamXBoVD8CWP6Rdlhj2MKcsRw7ilTl5AP8gsLDzgTszIJLTIn6iFLHuGKZ8pxgjZi2UJmfHnkWny-v30fP7aR4OKHkm5Q7p4g-bmg0nko019Gj5XTELW1unJ751TdGOfiLkZ0jar3wfzn1h8HxVud</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Dynamics of reproductive genetic technologies: Perspectives of professional stakeholders</title><source>Open Access: PubMed Central</source><source>ProQuest - Publicly Available Content Database</source><creator>Ivy van Dijke ; Carla G. van El ; Phillis Lakeman ; Mariëtte Goddijn ; Tessel Rigter ; Martina C. Cornel ; Lidewij Henneman</creator><creatorcontrib>Ivy van Dijke ; Carla G. van El ; Phillis Lakeman ; Mariëtte Goddijn ; Tessel Rigter ; Martina C. Cornel ; Lidewij Henneman</creatorcontrib><description>Reproductive and genetic medicine are evolving rapidly, and new technologies are already impacting current practices. This includes technologies that can identify a couples’ risk of having a child with a genetic disorder. Responsible implementation of new technologies requires evaluation of safety and ethics. Valuable insights for shaping governance processes are provided by various stakeholders involved, including healthcare professionals. Their willingness to adopt these technologies and guide the necessary systemic changes is required for the successful implementation of these technologies. In this study, twenty-one semi-structured interviews were conducted with professionals from different disciplines in the field of reproductive and genetic healthcare in the Netherlands. Three emerging technologies were discussed: expanded carrier screening (ECS), non-invasive prenatal diagnosis (NIPD) and germline genome editing (GGE). By probing stakeholders’ views, we explored how culture, structure and practice in healthcare is being shaped by innovations and changing dynamics in genetic and reproductive medicine. The general consensus was that the implementation of reproductive genetic technologies nationwide is a slow process in Dutch healthcare. A “typical Dutch approach” emerged that is characterized by restrictive legislation, broad support for people living with disabilities, values of an egalitarian society and limited commercialisation. Different scenarios for embedding ECS in future practice were envisioned, while implementation of NIPD in clinical practice was considered obvious. Views on GGE varied among stakeholders. Previous implementation examples in the Netherlands suggest introduction of new technology involves an organized collective learning process, with pilot studies and stepwise implementation. In addition, introducing and scaling up new technologies is complex due to perceived barriers from the legislative framework and the complex relationship between the government and stakeholders in this area. This paper describes how the international trends and advances of technologies are expected to manifest itself in a national setting.</description><identifier>EISSN: 1932-6203</identifier><language>eng</language><publisher>Public Library of Science (PLoS)</publisher><ispartof>PloS one, 2022-01, Vol.17 (6)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Ivy van Dijke</creatorcontrib><creatorcontrib>Carla G. van El</creatorcontrib><creatorcontrib>Phillis Lakeman</creatorcontrib><creatorcontrib>Mariëtte Goddijn</creatorcontrib><creatorcontrib>Tessel Rigter</creatorcontrib><creatorcontrib>Martina C. Cornel</creatorcontrib><creatorcontrib>Lidewij Henneman</creatorcontrib><title>Dynamics of reproductive genetic technologies: Perspectives of professional stakeholders</title><title>PloS one</title><description>Reproductive and genetic medicine are evolving rapidly, and new technologies are already impacting current practices. This includes technologies that can identify a couples’ risk of having a child with a genetic disorder. Responsible implementation of new technologies requires evaluation of safety and ethics. Valuable insights for shaping governance processes are provided by various stakeholders involved, including healthcare professionals. Their willingness to adopt these technologies and guide the necessary systemic changes is required for the successful implementation of these technologies. In this study, twenty-one semi-structured interviews were conducted with professionals from different disciplines in the field of reproductive and genetic healthcare in the Netherlands. Three emerging technologies were discussed: expanded carrier screening (ECS), non-invasive prenatal diagnosis (NIPD) and germline genome editing (GGE). By probing stakeholders’ views, we explored how culture, structure and practice in healthcare is being shaped by innovations and changing dynamics in genetic and reproductive medicine. The general consensus was that the implementation of reproductive genetic technologies nationwide is a slow process in Dutch healthcare. A “typical Dutch approach” emerged that is characterized by restrictive legislation, broad support for people living with disabilities, values of an egalitarian society and limited commercialisation. Different scenarios for embedding ECS in future practice were envisioned, while implementation of NIPD in clinical practice was considered obvious. Views on GGE varied among stakeholders. Previous implementation examples in the Netherlands suggest introduction of new technology involves an organized collective learning process, with pilot studies and stepwise implementation. In addition, introducing and scaling up new technologies is complex due to perceived barriers from the legislative framework and the complex relationship between the government and stakeholders in this area. This paper describes how the international trends and advances of technologies are expected to manifest itself in a national setting.</description><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqtjUFqwzAQRUUg0DTpHXSBgCLFkp1t2tLuuugiOzFIY0eJ4jEat5Db15gcoasPn_f-X4jVrjF6a7UyT-KZ-aJUZWprV-L0eu_hlgJLamXBoVD8CWP6Rdlhj2MKcsRw7ilTl5AP8gsLDzgTszIJLTIn6iFLHuGKZ8pxgjZi2UJmfHnkWny-v30fP7aR4OKHkm5Q7p4g-bmg0nko019Gj5XTELW1unJ751TdGOfiLkZ0jar3wfzn1h8HxVud</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Ivy van Dijke</creator><creator>Carla G. van El</creator><creator>Phillis Lakeman</creator><creator>Mariëtte Goddijn</creator><creator>Tessel Rigter</creator><creator>Martina C. Cornel</creator><creator>Lidewij Henneman</creator><general>Public Library of Science (PLoS)</general><scope>DOA</scope></search><sort><creationdate>20220101</creationdate><title>Dynamics of reproductive genetic technologies: Perspectives of professional stakeholders</title><author>Ivy van Dijke ; Carla G. van El ; Phillis Lakeman ; Mariëtte Goddijn ; Tessel Rigter ; Martina C. Cornel ; Lidewij Henneman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-doaj_primary_oai_doaj_org_article_e572ad266257477089377d1dde79084c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ivy van Dijke</creatorcontrib><creatorcontrib>Carla G. van El</creatorcontrib><creatorcontrib>Phillis Lakeman</creatorcontrib><creatorcontrib>Mariëtte Goddijn</creatorcontrib><creatorcontrib>Tessel Rigter</creatorcontrib><creatorcontrib>Martina C. Cornel</creatorcontrib><creatorcontrib>Lidewij Henneman</creatorcontrib><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ivy van Dijke</au><au>Carla G. van El</au><au>Phillis Lakeman</au><au>Mariëtte Goddijn</au><au>Tessel Rigter</au><au>Martina C. Cornel</au><au>Lidewij Henneman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dynamics of reproductive genetic technologies: Perspectives of professional stakeholders</atitle><jtitle>PloS one</jtitle><date>2022-01-01</date><risdate>2022</risdate><volume>17</volume><issue>6</issue><eissn>1932-6203</eissn><abstract>Reproductive and genetic medicine are evolving rapidly, and new technologies are already impacting current practices. This includes technologies that can identify a couples’ risk of having a child with a genetic disorder. Responsible implementation of new technologies requires evaluation of safety and ethics. Valuable insights for shaping governance processes are provided by various stakeholders involved, including healthcare professionals. Their willingness to adopt these technologies and guide the necessary systemic changes is required for the successful implementation of these technologies. In this study, twenty-one semi-structured interviews were conducted with professionals from different disciplines in the field of reproductive and genetic healthcare in the Netherlands. Three emerging technologies were discussed: expanded carrier screening (ECS), non-invasive prenatal diagnosis (NIPD) and germline genome editing (GGE). By probing stakeholders’ views, we explored how culture, structure and practice in healthcare is being shaped by innovations and changing dynamics in genetic and reproductive medicine. The general consensus was that the implementation of reproductive genetic technologies nationwide is a slow process in Dutch healthcare. A “typical Dutch approach” emerged that is characterized by restrictive legislation, broad support for people living with disabilities, values of an egalitarian society and limited commercialisation. Different scenarios for embedding ECS in future practice were envisioned, while implementation of NIPD in clinical practice was considered obvious. Views on GGE varied among stakeholders. Previous implementation examples in the Netherlands suggest introduction of new technology involves an organized collective learning process, with pilot studies and stepwise implementation. In addition, introducing and scaling up new technologies is complex due to perceived barriers from the legislative framework and the complex relationship between the government and stakeholders in this area. This paper describes how the international trends and advances of technologies are expected to manifest itself in a national setting.</abstract><pub>Public Library of Science (PLoS)</pub><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 1932-6203
ispartof PloS one, 2022-01, Vol.17 (6)
issn 1932-6203
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_e572ad266257477089377d1dde79084c
source Open Access: PubMed Central; ProQuest - Publicly Available Content Database
title Dynamics of reproductive genetic technologies: Perspectives of professional stakeholders
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T06%3A24%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dynamics%20of%20reproductive%20genetic%20technologies:%20Perspectives%20of%20professional%20stakeholders&rft.jtitle=PloS%20one&rft.au=Ivy%20van%20Dijke&rft.date=2022-01-01&rft.volume=17&rft.issue=6&rft.eissn=1932-6203&rft_id=info:doi/&rft_dat=%3Cdoaj%3Eoai_doaj_org_article_e572ad266257477089377d1dde79084c%3C/doaj%3E%3Cgrp_id%3Ecdi_FETCH-doaj_primary_oai_doaj_org_article_e572ad266257477089377d1dde79084c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true